MindWave calls Inscobee takeover attempt void, files legal action

MindWave (subsidiary of Apimeds/NYSE American: APUS) says Inscobee's March 20 written consent is void because 6,416,365 shares used were subject to an irrevocable proxy granted to APUS on Dec 1, 2025, and lacks the majority required under Delaware law. MindWave will file an emergency action in the Delaware Court of Chancery under 8 Del. C. § 225, seek a TRO, engage Seoul counsel and has notified its transfer agent and NYSE American. Separately, APUS stockholders removed director Erik Emerson on Dec 30, 2025; current APUS board is Elona Kogan, Jakap Koo, Carol O’Donnell and Dr. Bennett Weintraub. MindWave says it remains committed to completing the Preferred Stock conversion and the Merger Agreement transactions.

Analysis

A control-and-consent dispute introduces a legal overhang that is primarily a liquidity and volatility event rather than an immediate fundamental shock. Expect borrow costs and implied volatility to spike (histor analogs: IV +30–60%, borrow fees jumping from single digits to double- or triple-digit annualized rates) and NBBO spreads to widen materially for the micro-cap name, which compresses execution quality for both retail and institutional players.

Catalysts live on a short-to-medium timeline: intraday–weekly for transfer-agent or exchange actions and option/borrow squeezes, weekly–monthly for emergency judicial relief, and multi-month for any negotiated settlement or completion of corporate restructuring mechanics. Tail risks include a protracted cross-border enforcement fight and a failed conversion/merger that crystallizes permanent equity dilution or delisting risk; conversely, a rapid injunction that preserves the status quo typically re-compresses volatility within 2–6 weeks.

Second-order winners are liquidity-rich, high-growth public names that attract displaced capital flows; mid-cap AI/infra hardware and ad-tech leaders are plausible beneficiaries as quant and momentum desks reallocate. Market makers and volatility sellers face elevated inventory risk and will demand wider spreads and skew—creating opportunities for defined-risk option structures if you can time the judicial cadence correctly. The market often overshoots worst-case probabilities; if contractual defenses are robust, a swift recovery is possible once preliminary relief is granted.

Key Decisions for Investors

• Short APUS equity or buy a 3–6 month put spread sized to 2–3% of portfolio — target asymmetric payoff 2–4x if litigation derails the corporate action; cut position if shares rally >30% from entry or if a court issues a clear preservation order.
• Pair trade: short APUS / long SMCI (1:0.5 hedge ratio) for 3–6 months — rationale is capital rotation away from governance risk into liquid AI/infra names; target return 20–40% with stop if pair performance reverses by 15%.
• Volatility strategy: buy 3–6 month APUS puts (or a long-dated put ratio) if you expect protracted litigation; alternatively, if you expect rapid judicial preservation, sell short-dated calls or iron condors to collect premium — keep size small and limit gamma risk to <1% portfolio.